IGM Biosciences, Inc. (IGMS)
NASDAQ: IGMS · Real-Time Price · USD
15.65
-0.04 (-0.25%)
Nov 5, 2024, 12:44 PM EST - Market open

IGM Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Net Income
-220.4-246.42-221.1-165.16-81.36-43.13
Upgrade
Depreciation & Amortization
8.898.286.084.481.030.6
Upgrade
Loss (Gain) From Sale of Investments
-8.45-9.14-2.710.62-0.6-0.31
Upgrade
Stock-Based Compensation
37.5446.5544.7125.878.451.01
Upgrade
Other Operating Activities
14.2815.1912.012.752.551.74
Upgrade
Change in Accounts Payable
-0.15-0.99-30.652.21.96
Upgrade
Change in Unearned Revenue
-2.91-2.13148.93---
Upgrade
Change in Income Taxes
----0.04-
Upgrade
Change in Other Net Operating Assets
3.28-3.579.245.8-0.19-6.99
Upgrade
Operating Cash Flow
-167.92-192.23-5.85-124.98-67.88-45.12
Upgrade
Capital Expenditures
-8.23-12.38-10.21-13.24-17.5-2.34
Upgrade
Investment in Securities
46.2380.74-215.4428.7175.79-200.9
Upgrade
Investing Cash Flow
38.0368.36-225.6415.4658.29-203.24
Upgrade
Short-Term Debt Issued
-----15
Upgrade
Total Debt Issued
-----15
Upgrade
Net Debt Issued (Repaid)
-----15
Upgrade
Issuance of Common Stock
45.88115.07219.384.03216.51189.9
Upgrade
Repurchase of Common Stock
-0---1.56-1.73-
Upgrade
Other Financing Activities
-0.07-----4.64
Upgrade
Financing Cash Flow
45.81115.07219.382.48214.78282.26
Upgrade
Net Cash Flow
-84.08-8.81-12.12-107.05205.1933.9
Upgrade
Free Cash Flow
-176.15-204.61-16.06-138.23-85.38-47.45
Upgrade
Free Cash Flow Margin
-6051.15%-9606.20%-1502.25%---
Upgrade
Free Cash Flow Per Share
-2.93-3.91-0.39-4.13-2.78-5.28
Upgrade
Cash Interest Paid
-----0.3
Upgrade
Levered Free Cash Flow
-109.28-121.96-87.54-80.53-52.43-31.95
Upgrade
Unlevered Free Cash Flow
-109.28-121.96-87.54-80.53-52.43-31.95
Upgrade
Change in Net Working Capital
0.450.88-14.36-5.69-7.643.42
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.